one) and Drug Interactions (7)]. The potential risk of hypoglycemia may be lowered by a reduction during the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify patients employing these concomitant remedies of the risk of hypoglycemia and teach them to the signs and signs of hypoglycemia.Excretion The